The drug against dangerous bacteria, which do not take antibiotics, developed in Russia. Fluorothiazinone was created at the Gaama Center to fight Clivela pneumonia. It can cause severe pneumonia and pleurisy, kidney infections and sepsis. Resistant strains have recently been encountered in Europe. In some cases the mortality rate reaches 70%. According to the scientific director of the center Alexander Ginzburg, the drug helps to deal with such infections. At the Herzen Oncoinstitut, it is already used for severe complications after operations. According to the center, the drug helped save hundreds of patients. Follow Max I Feedback.